252 related articles for article (PubMed ID: 22361079)
1. Multiple biomarkers for risk prediction in chronic heart failure.
Ky B; French B; Levy WC; Sweitzer NK; Fang JC; Wu AH; Goldberg LR; Jessup M; Cappola TP
Circ Heart Fail; 2012 Mar; 5(2):183-90. PubMed ID: 22361079
[TBL] [Abstract][Full Text] [Related]
2. High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure.
Ky B; French B; McCloskey K; Rame JE; McIntosh E; Shahi P; Dries DL; Tang WH; Wu AH; Fang JC; Boxer R; Sweitzer NK; Levy WC; Goldberg LR; Jessup M; Cappola TP
Circ Heart Fail; 2011 Mar; 4(2):180-7. PubMed ID: 21178018
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients).
Lanfear DE; Levy WC; Stehlik J; Estep JD; Rogers JG; Shah KB; Boyle AJ; Chuang J; Farrar DJ; Starling RC
Circ Heart Fail; 2017 May; 10(5):. PubMed ID: 28465311
[TBL] [Abstract][Full Text] [Related]
4. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide.
May HT; Horne BD; Levy WC; Kfoury AG; Rasmusson KD; Linker DT; Mozaffarian D; Anderson JL; Renlund DG
Am J Cardiol; 2007 Aug; 100(4):697-700. PubMed ID: 17697831
[TBL] [Abstract][Full Text] [Related]
6. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.
Smith JG; Newton-Cheh C; Almgren P; Struck J; Morgenthaler NG; Bergmann A; Platonov PG; Hedblad B; Engström G; Wang TJ; Melander O
J Am Coll Cardiol; 2010 Nov; 56(21):1712-9. PubMed ID: 21070922
[TBL] [Abstract][Full Text] [Related]
7. Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study.
Wang TJ; Wollert KC; Larson MG; Coglianese E; McCabe EL; Cheng S; Ho JE; Fradley MG; Ghorbani A; Xanthakis V; Kempf T; Benjamin EJ; Levy D; Vasan RS; Januzzi JL
Circulation; 2012 Sep; 126(13):1596-604. PubMed ID: 22907935
[TBL] [Abstract][Full Text] [Related]
8. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
[TBL] [Abstract][Full Text] [Related]
9. A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial.
Demissei BG; Cotter G; Prescott MF; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Severin TM; Wang Y; Qian M; Teerlink JR; Metra M; Davison BA; Voors AA
Eur J Heart Fail; 2017 Aug; 19(8):1001-1010. PubMed ID: 28133908
[TBL] [Abstract][Full Text] [Related]
10. Prealbumin improves death risk prediction of BNP-added Seattle Heart Failure Model: results from a pilot study in elderly chronic heart failure patients.
Cabassi A; de Champlain J; Maggiore U; Parenti E; Coghi P; Vicini V; Tedeschi S; Cremaschi E; Binno S; Rocco R; Bonali S; Bianconcini M; Guerra C; Folesani G; Montanari A; Regolisti G; Fiaccadori E
Int J Cardiol; 2013 Oct; 168(4):3334-9. PubMed ID: 23623341
[TBL] [Abstract][Full Text] [Related]
11. ST2 pathogenetic profile in ambulatory heart failure patients.
Bayes-Genis A; Januzzi JL; Gaggin HK; de Antonio M; Motiwala SR; Zamora E; Galán A; Domingo M; Urrutia A; Lupón J
J Card Fail; 2015 Apr; 21(4):355-61. PubMed ID: 25451702
[TBL] [Abstract][Full Text] [Related]
12. The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure.
Ky B; French B; Ruparel K; Sweitzer NK; Fang JC; Levy WC; Sawyer DB; Cappola TP
J Am Coll Cardiol; 2011 Jul; 58(4):386-94. PubMed ID: 21757116
[TBL] [Abstract][Full Text] [Related]
13. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
[TBL] [Abstract][Full Text] [Related]
14. Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.
Lupón J; de Antonio M; Galán A; Vila J; Zamora E; Urrutia A; Bayes-Genis A
Mayo Clin Proc; 2013 Mar; 88(3):234-43. PubMed ID: 23384388
[TBL] [Abstract][Full Text] [Related]
15. Multimarker approach for the prediction of heart failure incidence in the community.
Velagaleti RS; Gona P; Larson MG; Wang TJ; Levy D; Benjamin EJ; Selhub J; Jacques PF; Meigs JB; Tofler GH; Vasan RS
Circulation; 2010 Oct; 122(17):1700-6. PubMed ID: 20937976
[TBL] [Abstract][Full Text] [Related]
16. Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failure.
Miller WL; Hartman KA; Grill DE; Struck J; Bergmann A; Jaffe AS
Heart; 2012 Mar; 98(5):389-94. PubMed ID: 22194151
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Seattle heart failure model and cardiopulmonary exercise capacity for prediction of death in patients with chronic ischemic heart failure and intracoronary progenitor cell application.
Honold J; DeRosa S; Spyridopoulos I; Fischer-Rasokat U; Seeger FH; Leistner D; Lotz S; Levy WC; Zeiher AM; Assmus B
Clin Cardiol; 2013 Mar; 36(3):153-9. PubMed ID: 23377956
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of galectin-3 on admission in Chinese patients with heart failure: a prospective observational study.
Wang H; Chen Q; Li Y; Jing X; Liang T; Yang J
Acta Cardiol; 2017 Apr; 72(2):188-195. PubMed ID: 28597803
[TBL] [Abstract][Full Text] [Related]
19. Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure.
Bayes-Genis A; de Antonio M; Galán A; Sanz H; Urrutia A; Cabanes R; Cano L; González B; Díez C; Pascual T; Elosúa R; Lupón J
Eur J Heart Fail; 2012 Jan; 14(1):32-8. PubMed ID: 22179033
[TBL] [Abstract][Full Text] [Related]
20. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.
Nakata T; Nakajima K; Yamashina S; Yamada T; Momose M; Kasama S; Matsui T; Matsuo S; Travin MI; Jacobson AF
JACC Cardiovasc Imaging; 2013 Jul; 6(7):772-84. PubMed ID: 23845574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
